FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 53 filers reported holding FATE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $68,000 | +78.9% | 15,000 | 0.0% | 0.00% | – |
Q4 2016 | $38,000 | -44.9% | 15,000 | -31.8% | 0.00% | -100.0% |
Q3 2016 | $69,000 | -6.8% | 22,000 | -50.0% | 0.00% | – |
Q2 2016 | $74,000 | +85.0% | 44,000 | +100.0% | 0.00% | -100.0% |
Q1 2016 | $40,000 | -88.1% | 22,000 | -78.0% | 0.00% | -80.0% |
Q4 2015 | $337,000 | -39.2% | 100,000 | -3.8% | 0.01% | -28.6% |
Q3 2015 | $554,000 | -14.4% | 104,000 | +4.0% | 0.01% | -12.5% |
Q2 2015 | $647,000 | – | 100,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |